Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by FARANAZ ATSCHEKZEI
GATA5 CpG Island Hypermethylation Is an Independent Predictor for Poor Clinical Outcome in Renal Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
MAPT Promoter CpG Island Hypermethylation Is Associated With Poor Prognosis in Patients With Stage II Colorectal Cancer
Cancer Management and Research
Oncology
PON1 Hypermethylation Is Associated With Progression of Renal Cell Carcinoma
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Differential Targets of CpG Island Hypermethylation in Primary and Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Journal of Medical Genetics
Genetics
Simultaneous CXCL12 and ESR1 CpG Island Hypermethylation Correlates With Poor Prognosis in Sporadic Breast Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Pretherapeutic Gamma-Glutamyltransferase Is an Independent Prognostic Factor for Patients With Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Preoperative Nutritional Status Is an Important Predictor of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma
European Urology
Urology
Epigenetic Inactivation of EGFR by CpG Island Hypermethylation in Cancer
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Low Level of PDZ Domain Containing 1 (PDZK1) Predicts Poor Clinical Outcome in Patients With Clear Cell Renal Cell Carcinoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology